Verrica Pharmaceuticals Inc. Investment Income, Interest
Verrica Pharmaceuticals Inc. (VRCA) reported Investment Income, Interest of $111.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-08-06
- Verrica Pharmaceuticals Inc. investment income, interest for the quarter ending 2026-06-30 was $111.00K, a 51.32% decline year-over-year.
- Verrica Pharmaceuticals Inc. investment income, interest for the quarter ending 2026-03-31 was $201.00K, a 40.36% decline year-over-year.
- Verrica Pharmaceuticals Inc. investment income, interest for the quarter ending 2025-12-31 was $205.00K, a 0.00% change year-over-year.
- Verrica Pharmaceuticals Inc. investment income, interest for the quarter ending 2025-09-30 was $159.00K, a 28.05% decline year-over-year.
- Verrica Pharmaceuticals Inc. investment income, interest for fiscal 2025 was $929.00K, a 34.44% decline from fiscal 2024.
- Verrica Pharmaceuticals Inc. investment income, interest for fiscal 2024 was $1.42M, a 48.28% decline from fiscal 2023.
- Verrica Pharmaceuticals Inc. investment income, interest for fiscal 2023 was $2.74M, a 475.63% increase from fiscal 2022.
- Verrica Pharmaceuticals Inc. investment income, interest for fiscal 2022 was $476.00K, a 286.99% increase from fiscal 2021.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $111.00K 10-Q · filed 2026-08-06 | $312.00K 10-Q · filed 2026-08-06 | $517.00K derived: sum of 3 quarters · filed 2026-08-06 | $676.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $201.00K 10-Q · filed 2026-05-12 | $406.00K derived: sum of 2 quarters · filed 2026-05-12 | $565.00K derived: sum of 3 quarters · filed 2026-05-12 | $793.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $205.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $364.00K derived: sum of 2 quarters · filed 2026-03-11 | $592.00K derived: sum of 3 quarters · filed 2026-08-06 | $929.00K 10-K · filed 2026-03-11 |
| 2025-09-30 | $159.00K 10-Q · filed 2025-11-14 | $387.00K derived: sum of 2 quarters · filed 2026-08-06 | $724.00K 10-Q · filed 2025-11-14 | $929.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $228.00K 10-Q · filed 2026-08-06 | $565.00K 10-Q · filed 2026-08-06 | $770.00K derived: sum of 3 quarters · filed 2026-08-06 | $991.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $337.00K 10-Q · filed 2026-05-12 | $542.00K derived: sum of 2 quarters · filed 2026-05-12 | $763.00K derived: sum of 3 quarters · filed 2026-05-12 | $1.16M derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $205.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $426.00K derived: sum of 2 quarters · filed 2026-03-11 | $819.00K derived: sum of 3 quarters · filed 2026-03-11 | $1.42M 10-K · filed 2026-03-11 |
| 2024-09-30 | $221.00K 10-Q · filed 2025-11-14 | $614.00K derived: sum of 2 quarters · filed 2025-11-14 | $1.21M 10-Q · filed 2025-11-14 | $2.00M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $393.00K 10-Q · filed 2025-08-12 | $991.00K 10-Q · filed 2025-08-12 | $1.78M derived: sum of 3 quarters · filed 2025-08-12 | $2.60M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $598.00K 10-Q · filed 2025-05-13 | $1.39M derived: sum of 2 quarters · filed 2025-05-13 | $2.21M derived: sum of 3 quarters · filed 2025-05-13 | $2.84M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $792.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $1.61M derived: sum of 2 quarters · filed 2025-03-11 | $2.24M derived: sum of 3 quarters · filed 2025-03-11 | $2.74M 10-K · filed 2025-03-11 |
| 2023-09-30 | $822.00K 10-Q · filed 2024-11-05 | $1.45M derived: sum of 2 quarters · filed 2024-11-05 | $1.95M 10-Q · filed 2024-11-05 | $2.23M derived: sum of 4 quarters · filed 2024-11-05 |
| 2023-06-30 | $626.00K 10-Q · filed 2024-08-14 | $1.13M 10-Q · filed 2024-08-14 | $1.41M derived: sum of 3 quarters · filed 2024-08-14 | $1.56M derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $500.00K 10-Q · filed 2024-05-13 | $786.00K derived: sum of 2 quarters · filed 2024-05-13 | $934.00K derived: sum of 3 quarters · filed 2024-05-13 | $954.00K derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $286.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $434.00K derived: sum of 2 quarters · filed 2024-02-29 | $454.00K derived: sum of 3 quarters · filed 2024-02-29 | $476.00K 10-K · filed 2024-02-29 |
| 2022-09-30 | $148.00K 10-Q · filed 2023-11-09 | $168.00K derived: sum of 2 quarters · filed 2023-11-09 | $190.00K 10-Q · filed 2023-11-09 | $217.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $20.00K 10-Q · filed 2023-08-08 | $42.00K 10-Q · filed 2023-08-08 | $69.00K derived: sum of 3 quarters · filed 2023-08-08 | $100.00K derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $22.00K 10-Q · filed 2023-05-09 | $49.00K derived: sum of 2 quarters · filed 2023-05-09 | $80.00K derived: sum of 3 quarters · filed 2023-05-09 | $113.00K derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $27.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $58.00K derived: sum of 2 quarters · filed 2023-03-06 | $91.00K derived: sum of 3 quarters · filed 2023-03-06 | $123.00K 10-K · filed 2023-03-06 |
| 2021-09-30 | $31.00K 10-Q · filed 2022-11-07 | $64.00K derived: sum of 2 quarters · filed 2022-11-07 | $96.00K 10-Q · filed 2022-11-07 | $144.00K derived: sum of 4 quarters · filed 2022-11-07 |
| 2021-06-30 | $33.00K 10-Q · filed 2022-08-11 | $65.00K 10-Q · filed 2022-08-11 | $113.00K derived: sum of 3 quarters · filed 2022-08-11 | $182.00K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $32.00K 10-Q · filed 2022-05-09 | $80.00K derived: sum of 2 quarters · filed 2022-05-09 | $149.00K derived: sum of 3 quarters · filed 2022-05-09 | $275.00K derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | $48.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-02 | $117.00K derived: sum of 2 quarters · filed 2022-03-02 | $243.00K derived: sum of 3 quarters · filed 2022-03-02 | $521.00K 10-K · filed 2022-03-02 |
| 2020-09-30 | $69.00K 10-Q · filed 2021-11-12 | $195.00K derived: sum of 2 quarters · filed 2021-11-12 | $473.00K 10-Q · filed 2021-11-12 | $827.00K derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | $126.00K 10-Q · filed 2021-08-10 | $404.00K 10-Q · filed 2021-08-10 | $758.00K derived: sum of 3 quarters · filed 2021-08-10 | $1.21M derived: sum of 4 quarters · filed 2021-08-10 |
| 2020-03-31 | $278.00K 10-Q · filed 2021-05-07 | $632.00K derived: sum of 2 quarters · filed 2021-05-07 | $1.08M derived: sum of 3 quarters · filed 2021-05-07 | $1.61M derived: sum of 4 quarters · filed 2021-05-07 |
| 2019-12-31 | $354.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-17 | $807.00K derived: sum of 2 quarters · filed 2021-03-17 | $1.33M derived: sum of 3 quarters · filed 2021-03-17 | $1.88M 10-K · filed 2021-03-17 |
| 2019-09-30 | $453.00K 10-Q · filed 2020-11-09 | $976.00K derived: sum of 2 quarters · filed 2020-11-09 | $1.52M 10-Q · filed 2020-11-09 | $2.13M derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | $523.00K 10-Q · filed 2020-08-05 | $1.07M 10-Q · filed 2020-08-05 | $1.68M derived: sum of 3 quarters · filed 2020-08-05 | $2.11M derived: sum of 4 quarters · filed 2020-08-05 |
| 2019-03-31 | $547.00K 10-Q · filed 2020-05-07 | $1.16M derived: sum of 2 quarters · filed 2020-05-07 | $1.58M derived: sum of 3 quarters · filed 2020-05-07 | $1.74M derived: sum of 4 quarters · filed 2020-05-07 |
| 2018-12-31 | $610.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $1.04M derived: sum of 2 quarters · filed 2020-03-13 | $1.19M derived: sum of 3 quarters · filed 2020-03-13 | $1.23M 10-K · filed 2020-03-13 |
| 2018-09-30 | $427.00K 10-Q · filed 2019-11-06 | $580.00K derived: sum of 2 quarters · filed 2019-11-06 | $621.00K 10-Q · filed 2019-11-06 | |
| 2018-06-30 | $153.00K 10-Q · filed 2019-08-07 | $194.00K 10-Q · filed 2019-08-07 | ||
| 2018-03-31 | $41.00K 10-Q · filed 2019-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |